Takeda (NYSE: TAK) CFO details share holdings, RSUs and tax awards

Rhea-AI Filing Summary

Takeda Pharmaceutical’s Chief Financial Officer Furuta Milano has filed an initial ownership report showing existing equity interests. The filing lists direct ownership of 50,100 Ordinary Shares, including 19,500 restricted stock units (RSUs).

The RSUs represent a contingent right to receive one Ordinary Share each, vesting on June 1, 2026 (8,400 shares), June 1, 2027 (7,100 shares) and June 1, 2028 (4,000 shares). The report also shows several Tax Obligation Awards, each economically equivalent to one Ordinary Share, that upon vest will be settled in cash primarily to cover tax obligations at the then-current market price, rather than delivering shares. These entries reflect reported holdings rather than open‑market buying or selling.

Insights

Equity compensation analyst

Routine Form 3 showing Takeda CFO’s existing share, RSU and tax award holdings.

The filing records Furuta Milano as Takeda’s Chief Financial Officer with direct ownership of 50,100 Ordinary Shares. This includes 19,500 RSUs that convert into shares on a set vesting schedule through June 1, 2028, indicating a standard long-term incentive structure.

In addition, the Form 3 lists several Tax Obligation Awards, each economically equivalent to one Ordinary Share but designed to settle in cash at the then-current share price to cover tax liabilities when they vest. Because there are no buy or sell codes and the transaction summary is neutral, this appears to be a disclosure of existing positions rather than new market transactions.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Furuta Milano

(Last) (First) (Middle)

1-1, NIHONBASHI-HONCHO 2-CHOME

CHUO-KU

(Street)

TOKYO 103-8668

(City) (State) (Zip)

JAPAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	50,100(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Tax Obligation Award	06/01/2026	06/01/2026	Ordinary Shares	8,805	(2)	D
Tax Obligation Award	06/01/2027	06/01/2027	Ordinary Shares	7,453	(2)	D
Tax Obligation Award	06/01/2028	06/01/2028	Ordinary Shares	4,194	(2)	D

Explanation of Responses:

1. Includes 19,500 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (8,400 shares), June 1, 2027 (7,100 shares) and June 1, 2028 (4000 shares).

2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Milano Furuta	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What share holdings does Takeda (TAK) CFO Furuta Milano report on this Form 3?

Furuta Milano reports direct ownership of 50,100 Ordinary Shares of Takeda. This total includes 19,500 restricted stock units (RSUs) that will convert into Ordinary Shares as they vest over time, reflecting her existing equity stake in the company.

How many RSUs does Takeda (TAK) CFO Furuta Milano hold and when do they vest?

The Form 3 shows 19,500 RSUs for Furuta Milano. They vest in three tranches: 8,400 shares on June 1, 2026, 7,100 shares on June 1, 2027, and 4,000 shares on June 1, 2028, each converting into one Ordinary Share upon vesting.

What are the Tax Obligation Awards reported by Takeda (TAK) CFO Furuta Milano?

The Tax Obligation Awards are instruments economically equivalent to Ordinary Shares that, upon vesting, convert into a cash payment at the then-current share price. The cash is used primarily to cover tax obligations, rather than delivering additional shares to the executive.

Does this Takeda (TAK) Form 3 show the CFO buying or selling shares?

The Form 3 does not show explicit buy or sell transactions. It records existing holdings of Ordinary Shares, RSUs, and Tax Obligation Awards with transaction codes marked as unknown, indicating a position disclosure rather than new open‑market trades.

How are the RSUs described in Takeda (TAK) CFO Furuta Milano’s Form 3?

Each RSU is described as a contingent right to receive one Ordinary Share. They are part of her equity compensation and will convert into Ordinary Shares only as they vest on the scheduled dates in 2026, 2027, and 2028.

How do the Tax Obligation Awards for Takeda (TAK) CFO settle at vesting?

Each Tax Obligation Award is economically equivalent to one Ordinary Share but is settled in cash at vesting. The cash amount is based on the then-current market price of the Ordinary Shares and is used primarily to cover related tax obligations.